Published in Biomedicine on October 01, 1978
Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa. Clin Exp Immunol (1980) 0.88
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Support Care Cancer (2012) 1.45
[Transfusional strategy in neurosurgery: preoperative hemodilution by erythrocytapheresis]. Ann Fr Anesth Reanim (1994) 1.39
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis (1976) 1.32
[Hyperlipidemia caused by anti-beta-lipoprotein autoantibodies. A new pathological entity]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.21
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation (1999) 1.21
Auto-immune hyperlipidemia. An atherogenic metabolic disease of immune origin. Rev Eur Etud Clin Biol (1970) 1.15
Antiethinyloestradiol antibody activities in oral contraceptive users. Clin Exp Immunol (1979) 1.12
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J Clin Invest (1993) 0.99
Oral contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG. Clin Exp Immunol (1976) 0.98
Autoimmune hyperlipidemia. Atherosclerosis (1977) 0.98
Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis. Am J Reprod Immunol (1982) 0.93
[Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins (author's transl)]. Pathol Biol (Paris) (1978) 0.91
Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine. Arterioscler Thromb Vasc Biol (1998) 0.89
[Use of a detergent for the purification of antilipoprotein antibodies]. Immunochemistry (1970) 0.89
Functional analysis of the chimpanzee and human apo(a) promoter sequences: identification of sequence variations responsible for elevated transcriptional activity in chimpanzee. J Biol Chem (2001) 0.89
[Presence of an anti-beta-lipoprotein autoantibody in a myeloma serum]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.89
The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Ann Oncol (2012) 0.89
Tobacco and other factors in the etiology of ischemic heart disease in man: results of a retrospective survey. J Chronic Dis (1966) 0.89
[Gamma globulins and hyperlipemia. Hyperlipemia caused by autoantibodies]. Ann Biol Clin (Paris) (1970) 0.88
Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. Arterioscler Thromb Vasc Biol (1999) 0.88
Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa. Clin Exp Immunol (1980) 0.88
[A common specificity in serum alpha and beta-lipoproteins demonstrated by a myeloma auto-antibody. The Pg antigen]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.88
A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man. Eur J Clin Pharmacol (1975) 0.87
[Myeloma anti-lipoprotein autoantibodies. Comparative study of 2 types anti-Lp P.G. IgA and anti-Lp A.S. IgG]. Ann Biol Clin (Paris) (1970) 0.86
Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology (1999) 0.84
[Myeloma and hyperlipemia. IV. Nature of the specific anti-lipoprotein activity]. Nouv Rev Fr Hematol (1967) 0.83
[Myeloma, hyperlipemia and xanthomatosis]. Nouv Rev Fr Hematol (1965) 0.83
[Hyperlipidemia caused by auto-antibodies. A cause of atherosclerosis]. Presse Med (1967) 0.83
[Detection of pill-induced antiethinylestradiol antibodies (author's transl)]. Ann Biol Clin (Paris) (1981) 0.82
[Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity]. Sem Hop (1975) 0.82
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metabolism (1992) 0.82
Cholesterol synthesis by human fibroblasts in the presence of LDL and anti-LDL IgA. Biomedicine (1979) 0.82
Detection and composition of circulating immune complexes in oral contraceptive users. Biomedicine (1979) 0.82
[A myeloma gamma A-globulin with a specific anti-lipoprotein activity. The anti-Pg autoantibody]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.81
Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta (1990) 0.81
[Passive hemagglutination with chromium chloride. Its use without macromolecular dilution]. Pathol Biol (Paris) (1969) 0.81
[Experimental hyperlipemia induced by immunization in the rabbit]. Pathol Biol (1968) 0.81
The promoter of human tissue factor pathway inhibitor gene: identification of potential regulatory elements. Thromb Res (1999) 0.80
[A second type of myeloma antilipoprotein autoantibody: IgG anti-Lp A1]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.80
[Anti-heparin immunoglobulins, a factor of thrombosis, hyperlipemia and atherosclerosis]. Pathol Biol (Paris) (1974) 0.80
Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells. Arterioscler Thromb Vasc Biol (1997) 0.80
[A further case of hyperlipemia due to auto-antibodies. Its treatment with D-penicillamine]. Bull Mem Soc Med Hop Paris (1967) 0.80
[Blood triglycerides in a professional group]. J Atheroscler Res (1967) 0.79
[Immunochemical study of the lipoprotein substance Pg (author's transl)]. Pathol Biol (Paris) (1977) 0.79
Antiestrogen antibodies, oral contraception and systemic lupus erythematosus. Clin Physiol Biochem (1989) 0.79
Modification in the composition and metabolic properties of human low density and high density lipoproteins by different dietary fats. J Lipid Res (1984) 0.79
Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Artery (1982) 0.78
Effects of three dietary fats on plasma lipids and lipoproteins in fasting and post-prandial humans after a short-term diet. Lipids (1980) 0.78
Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia. Atherosclerosis (1977) 0.78
Plateletpheresis concentrates produced with the COMTEC cell separator: the French experience. Transfus Apher Sci (2001) 0.78
Dietary modifications of low-density lipoprotein fatty acids in humans: their effect on low-density lipoprotein-fibroblast interactions. Clin Physiol Biochem (1986) 0.78
The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia. Atherosclerosis (1985) 0.78
[Cholestatic viral hepatitis A in adults. Clinical, biological and histopathological study of 9 cases]. Gastroenterol Clin Biol (1994) 0.78
[Purification of serum alpha-1-lipoproteins]. Ann Biol Clin (Paris) (1970) 0.78
[Method of purification of rabbit antibody against human beta lipoprotein starting with specific precipitates]. Immunochemistry (1969) 0.78
[The specific activity of the M proteins. "Towards a new criterion for the classification of the myelomas and macroglobulinemias"]. Rev Fr Etud Clin Biol (1967) 0.78
[Presence of a phospholipid in the Pg site that reveals IgA myelomatous antilipoprotein (anti-Pg) ]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.78
A new serum lipoprotein associated erythrocyte antigen which reacts with a monoclonal IgM. The stored human red blood cell SHRBC antigen. Vox Sang (1976) 0.78
[An anti-heparin immunoglobulin in a hyperlipidemic serum. (A new variety of auto-antibody hyperlipidemia)]. C R Acad Sci Hebd Seances Acad Sci D (1970) 0.77
[Presence of an anti-beta-lipoprotein auto-antibody in the serum of a rabbit having a hyperlipidemia by immunization (hyperlipidemia by experimental auto-antibodies)]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.77
[Agglutination phenomenon of lipid particles. Its value in sero-immunology]. Pathol Biol (Paris) (1972) 0.77
Immunogenicity and the vascular risk of oral contraceptives. Br Heart J (1985) 0.77
Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop). Atherosclerosis (1997) 0.77
[A method for the purification of serum beta-lipoproteins]. Ann Biol Clin (Paris) (1968) 0.77
[The phenomenon of agglutination of lipid particles in hyperlipidemia by autoantibodies. Test of agglutination of activated lipid amulsions (AALE)]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.76
Vascular thrombosis and oral contraceptives - a risk correlated study. J Med (1981) 0.76
Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases. Eur Heart J (1991) 0.76
Antiethinyl estradiol antibodies. Neurology (1993) 0.75
Thrombosis and antibodies to cyproterone acetate. Lancet (1991) 0.75
Nephrotic syndrome, monoclonal gammopathy and auto-immune hyperlipidaemia. Clin Exp Immunol (1974) 0.75
[Transformations of the cholesterol molecule in vitro. Their importance during chromatographic analyses]. J Chromatogr (1966) 0.75
[Anti-lipoprotein autoantibodies (anti-Pg) of gamma-A-myeloma with hyperlipidemia: method of isolation and purification from circulating complexes]. Ann Biol Clin (Paris) (1968) 0.75
[Cholesterol turnover in the aorta and subcutaneous granulomas in the rat]. Rev Atheroscler (Paris) (1969) 0.75
[Comparative study of the cholesterol level of the aortic intima and of the connective tissue cultivated "in vivo"]. Pathol Biol (1966) 0.75
[Arterial ischemic syndrome associated with plasma cryoprecipitation and cutaneous porphyria in adults]. Presse Med (1970) 0.75
[Separation and purification of alpha and betalipoproteins in the rat]. Ann Biol Clin (Paris) (1970) 0.75
[Blood lipoprotein transfers in the normal arterial wall. Study auto-historadiography in optic microscopy]. Paroi Arterielle (1975) 0.75
[Epidemiological survey on various factors in atherosclerosis. (Initial results 1963-1964). Arterial pressure distribution and correlation in one professional group]. Bull Inst Natl Sante Rech Med (1968) 0.75
[Amino acids in beta lipoproteins of normal human serum]. Pathol Biol (Paris) (1970) 0.75
[Epidemiological survey on various factors in atherosclerosis. (Initial results 1963-1964). Cholesterolemia]. Bull Inst Natl Sante Rech Med (1968) 0.75
[Diphtheric myocarditis. Apropos of a clinical case]. Ann Med Interne (Paris) (1971) 0.75
[Composition of the beta-lipoproteins in normal subjects and in xanthomatous familial hypercholesterolemia]. Pathol Biol (Paris) (1970) 0.75
[Criteria necessary for evaluating the action of hypocholesterolemic drugs in man]. Bull Inst Natl Sante Rech Med (1966) 0.75
[Prevention of certain acute and chronic effects of nicotine by N-acetylhydroxyproline]. Pathol Biol (Paris) (1971) 0.75
Effect of factors influencing the reticuloendothelial system on the turnover of the rat serum cholesterol. Nutr Metab (1971) 0.75
In vivo incorporation of dietary ( 14 C)cholesterol in rat serum lipoproteins and transfers in connective tissue. Clin Chim Acta (1971) 0.75
Circulating lipophages and aortic foam cells in experimental atherosclerosis of rabbits under altered reticuloendothelial activity. Nutr Metab (1976) 0.75
[Association of monoclonal gammopathy with chronic glomerulonephritis and autoimmune hyperlipemia. Course of disease during therapy]. Nouv Presse Med (1976) 0.75
[Oral vitamin A tolerance tests in hypertriglyceridemia (author's transl)]. Pathol Biol (Paris) (1976) 0.75
[Myeloma, hyperlipidemia and xanthomatosis. 3. A syndrome due to the presence of an anti-beta-lipoprotein autoantibody]. Nouv Rev Fr Hematol (1966) 0.75
[Epidemiological survey on various factors in atherosclerosis. (Initial results 1963-1964). Blood triglycerides]. Bull Inst Natl Sante Rech Med (1968) 0.75